The question as to whether identification and treatment of post-MI depression can improve cardiovascular prognosis remains unanswered: an adequately powered trial that incorporates managed care in the intervention arm is required. This trial does, however, provide further evidence for the view that we should not be screening for depression until we have set in place efficient and effective management programmes.